NCT04028336

Brief Summary

Pulmonary recruitment maneuvers open these lung areas and appropriate adjustment of positive expiratory pressure (PEP) helps to stabilize recruitment and reduce the stress associated with alveolar opening and closing. Its beneficial effects in the lung affected by Acute Respiratory Distress Syndrome (ARDS) remain unclear. The hypothesis is that there is a heterogeneous effect of the recruitment maneuver according to the phenotype of ARDS. It is important to be able to define responder patients from non-responders to this recruiting maneuver.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

4 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 22, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

December 20, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 7, 2021

Completed
Last Updated

March 4, 2021

Status Verified

March 1, 2021

Enrollment Period

1.1 years

First QC Date

July 9, 2019

Last Update Submit

March 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • oxygenation and pulmonary compliance

    The primary outcome is oxygenation (PaO2 / FiO2) and pulmonary compliance ((Pplat-Pep) / VT) at 1h of the PEP-OP test.

    at 1 hours of the PEP-OP test.

Secondary Outcomes (6)

  • Oxygenation (PaO2 / FiO2) at 6h, 12h, 24h

    at 6 hours, 12 hours, 24 hours of the PEP-OP test

  • Mechanical ventilation time

    Discharge from intensive care unit

  • Hospitalization in intensive care time

    Discharge from intensive care unit

  • The need for recourse to alternative therapies of oxygenation

    Discharge from intensive care unit

  • Incidence of barotrauma

    After PEP-OP

  • +1 more secondary outcomes

Study Arms (1)

TITRATION

EXPERIMENTAL

All patients hospitalized in intensive care and meeting inclusion criteria and without criteria for non-inclusion will be included in this study. All patients will benefit from Lung ultrasound (LUS) and esophageal pressure measurement (Peso) according to the habits of the service. A "PEP titration pulmonary opening" (PEP-OP) test using a recruitment maneuver was then performed in all patients followed by a new LUS and Peso measurement.

Other: TITRATION

Interventions

PEP titration pulmonary opening (PEP-OP) was performed in all patients followed by new LUS and Peso measurement.

TITRATION

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Will be included in the study, patients:
  • Major patient (age ≥18 years)
  • Controlled assisted ventilation, sedation and curarization adapted to the respirator.
  • Within the first 72 hours of an ARDS (PaO2 / FiO2 ≤ 200 mmHg, FiO2 ≥ 60% and PEEP of ≥5 cmH20) (as recommended by the Berlin criteria)
  • Decision of intensivist in charge of the patient to put an oesophageal probe
  • After hemodynamic optimization (evaluation of the preload dependence and need for catecholamines)
  • Decision of the intensivist in charge of the patient to perform a pulmonary opening test by titration of PEEP by means of a pulmonary recruitment test.

You may not qualify if:

  • Patients under the age of 18
  • Pregnant women, women who are parturient or breastfeeding
  • Patients with pulmonary broncho-emphysematous pathology or at risk of presenting it.
  • Patients with a history of barotrauma or at risk of presenting it.
  • Patients with a history of intracranial hypertension
  • Patients with suspected or proven right ventricular dysfunction or uncontrolled hemodynamic instability after hemodynamic management.
  • Patients with a contraindication to the placement of an oesophageal tube (esophageal surgery, severe esophageal pathology)
  • Patients under guardianship or curatorship or deprived of liberty.
  • Patients who are legally protected
  • Patient not covered by French national health insurance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Chu Amiens

Amiens, 80054, France

Location

CH Arras

Arras, 62000, France

Location

Ch Germon Et Gauthier

Béthune, 62408, France

Location

Hospital Dr Schaffner

Lens, 62307, France

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Julien MARC, DR

    Hospital of Lens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: All patients in intensive care and severe, moderate ARDS will be included in this study. All patients will benefit from Lung ultrasound (LUS) with a mapping of each lung looking for normal or pathological lung profiles, as well as a measurement of esophageal pressure (Peso) at rest. A "PEP titration pulmonary opening" (PEP-OP) test using a recruitment maneuver was then performed in all patients followed by a new LUS and Peso measurement.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2019

First Posted

July 22, 2019

Study Start

December 20, 2019

Primary Completion

January 7, 2021

Study Completion

January 7, 2021

Last Updated

March 4, 2021

Record last verified: 2021-03

Locations